Visceral leishmaniasis: a new opportunistic infection in hematopoietic stem-cell-transplanted patients.
Sirvent-von Bueltzingsloewen
A
A
Marty
P
P
Rosenthal
E
E
Delaunay
P
P
Allieri-Rosenthal
A
A
Gratecos
N
N
Cassuto
J P
JP
D000666:Amphotericin B / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000635:transmission*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000469:parasitology; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D000666:Amphotericin B